ENTITY

Immunovant Inc (IMVT US)

Analysis

Health Care • United States

Immunovant Inc operates as a biopharmaceutical company. The Company offers discovers and manufactures drugs for patients with autoimmune diseases. Immunovant serves customers worldwide.

Refresh

Focused

No publications yet

There aren’t any syndicated reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00